2025 revenue consensus $438.17M. Narrows 2025 adjusted EBITDA view to $88M-$91M vs. $86M-$91M.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AORT:
- Artivion announces treatment of first patient in ARTIZEN pivotal trial
- AORT Upcoming Earnings Report: What to Expect?
- Artivion Inc. Advances Aortic Treatment with New Clinical Study
- Artivion announces data from AMDS PERSEVERE and PROTECT trials
- Artivion price target raised to $47 from $42 at Citizens JMP